A prospective, one-arm, phase I study of high-memory phenotypic tumor-infiltrating T lymphocytes (TILs) combined with teriprizumab in the treatment of advanced melanoma
Latest Information Update: 03 Dec 2020
At a glance
- Drugs Toripalimab (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- 03 Dec 2020 New trial record